The pharmacokinetics of bendazac-lysine and 5-hydroxybendazac, its main metabolite, in patients with hepatic cirrhosis
β Scribed by V. Rovei; J. Escourrou; G. Campistron; D. Ego; A. Thiola; A. Ribet; G. Houin
- Publisher
- Springer
- Year
- 1988
- Tongue
- English
- Weight
- 533 KB
- Volume
- 35
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The pharmacokinetic behaviour of glycyrrhizin in four patients with acute hepatitis (hepatitis group) and six patients with liver cirrhosis (cirrhosis group) receiving chronically an IV administration of a 120 mg dose once a day or once every other day of glycyrrhizin was investigated. The plasma co
The relationships between the pharmacokinetic behaviour of glycyrrhizin and its restorative eect for hepatic function were investigated in patients with chronic hepatitis and in rats chronically treated with carbon tetrachloride (CCl 4 -treated rats). In patients, the restorative eects in plasma asp